Discontinued — last reported Q4 '25
Lumentum Holdings Inc. Interest Paid decreased by 75.5% to $2.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1150.0%, from $200.00K to $2.50M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 31.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.60M | $600.00K | $2.60M | $600.00K | $3.70M | $600.00K | $4.80M | $600.00K | $4.80M | $600.00K | $9.30M | $500.00K | $9.30M | $100.00K | $9.40M | $200.00K | $9.40M | $100.00K | $10.20M | $2.50M |
| QoQ Change | — | -76.9% | +333.3% | -76.9% | +516.7% | -83.8% | +700.0% | -87.5% | +700.0% | -87.5% | >999% | -94.6% | >999% | -98.9% | >999% | -97.9% | >999% | -98.9% | >999% | -75.5% |
| YoY Change | — | — | — | — | +42.3% | +0.0% | +84.6% | +0.0% | +29.7% | +0.0% | +93.8% | -16.7% | +93.8% | -83.3% | +1.1% | -60.0% | +1.1% | +0.0% | +8.5% | >999% |